Last updated Nov 10, 2026
A macrocephalic infant develops acute dystonia after a febrile illness. MRI shows frontotemporal atrophy and basal ganglia injury.
AR; GCDH (glutaryl-CoA dehydrogenase, a mitochondrial enzyme of lysine, hydroxylysine, and tryptophan breakdown). Biallelic loss-of-function variants, most of them missense.
Glutaryl-CoA dehydrogenase is a mitochondrial enzyme in the breakdown of lysine, hydroxylysine, and tryptophan. Biallelic GCDH variants, most of them missense, reduce or abolish its activity; many probably destabilize the enzyme complex. The upstream products accumulate: glutaric acid (probably from hydrolysis of trapped glutaryl-CoA), 3-hydroxyglutaric acid, glutarylcarnitine (C5DC), and glutaconic acid.
Glutaric and 3-hydroxyglutaric acids are neurotoxic, above all to the striatum, which is the injury behind sudden dystonia during an illness-triggered crisis. Why the striatum is targeted, and why vulnerability peaks in infancy and early childhood, is unknown. Macrocephaly with frontotemporal hypoplasia stretches bridging veins across enlarged fluid spaces, the probable cause of subdural hemorrhage.
Excreter status follows residual activity:
- High excreters: 0% to 3% activity; newborn screening finds all of them.
- Low excreters: up to 30% activity, with at least one hypomorphic missense variant (homozygous p.Arg227Pro or p.Val400Met keeps 8% to 10%). Screening on C5DC finds about 84%, so a normal screen does not exclude GA1.
Both groups carry a similar risk of striatal injury.
Part of lysine catabolism.
Lysine, hydroxylysine, and tryptophan catabolism, which converges on glutaryl-CoA.
lysine, hydroxylysine, tryptophan → glutaryl-CoA → glutaryl-CoA dehydrogenase (the block) → crotonyl-CoA → Krebs cycle
- Accumulates: glutaryl-CoA, measured as glutarylcarnitine (C5DC) on newborn screening and as glutaric and 3-hydroxyglutaric acids in urine; low excreters can show little.
- Missing: crotonyl-CoA and its entry into the Krebs cycle; the harm comes from the toxic buildup in the brain.
- Workbook: 4.L. Glutaric acidemia type I (GA-I)
- Lysine/tryptophan degradation defect
- Macrocephaly
- Acute encephalopathic crises → dystonia
- MRI: widened sylvian fissures, "bat wing" appearance
- On RUSP
- On RUSP: flagged by elevated glutarylcarnitine (C5-DC) on newborn screening acylcarnitine profile
- Urine organic acids: elevated glutaric and 3-hydroxyglutaric acid (low-excretor phenotype can have minimal organic aciduria)
- Confirmation: deficient glutaryl-CoA dehydrogenase activity or biallelic GCDH variants
- Lysine restriction, carnitine, aggressive management during illness
GA1 has a "G1Ant head": macrocephaly is a hallmark. "91utaric": reverse 9 and 1 to get chromosome 19 (location of GCDH).
NBS: elevated C5-DC (glutarylcarnitine): on newborn screening, C5-DC is the key acylcarnitine marker.
Lysine and Tryptophan in gLuTaric acidemia: these are the two amino acids whose degradation is impaired. Basal ganGLia are affected in GLutaric acidemia, causing movement disorders (cognition spared).
This diagram compares the biochemical pathways of GA1 (GCDH deficiency) and GA2 (ETF/electron transfer deficiency), showing how both converge on FAD metabolism.
